About Safety Net Hospitals for Pharmaceutical Access (SNHPA)
Safety Net Hospitals for Pharmaceutical Access (SNHPA) is an organization of over 400 public and private non-profit hospitals and health systems throughout the U.S. that participate in the Public Health Service 340B drug discount program. SNHPA, which was originally named the Public Hospital Pharmacy Coalition, was formed in 1993 to increase the affordability and accessibility of pharmaceutical care for the nation's poor and underserved populations. When Congress was creating the 340B program in 1992, SNHPA took the lead role in ensuring that hospitals were included in the program and the organization has been representing the interests of 340B hospitals ever since. SNHPA monitors, educates, and serves as an advocate on federal legislative and regulatory issues related to drug pricing and other pharmacy matters affecting safety-net providers. SNHPA is dedicated to educating its members and others about the 340B program and creating new opportunities for members to save on pharmaceuticals and improve access to pharmaceutical care.
Our hospital has been a member of Safety Net Hospitals for Pharmaceutical Access since its formation in 1993. The services provided by SNHPA, the drug pricing reports, sub-ceiling price surveys, the advocacy and networking opportunities, to name only a few, have made membership in SNHPA an invaluable tool in our quest to provide care to patients in need. The membership fee has been a great investment in the process of saving several million dollars each year.
-
Andrew Lowe, Pharm.D.
Director of Pharmacy
Arrowhead Regional Medical Center
Colton, CA
Mission Statement
To monitor, educate and serve as an advocate on behalf of the Association’s members with respect to federal legislative and regulatory matters pertaining to the Public Health Service 340B drug discount program and other pharmacy matters in an effort to increase the affordability and accessibility of pharmaceutical care for the underserved in this nation.
Learn more about The Monitor, a monthly publication covering the latest news in the 340B program and other federal drug discount programs.
Washington, DC 20005 
